Neuropilin-1 mediates myeloid cell chemoattraction and influences retinal neuroimmune crosstalk

Journal of Clinical Investigation

Volumn 124, Issue 11, 2014, Pages 4807-4822

  Dejda, Agnieszka ^a   Mawambo, Gaelle ^a   Cerani, Agustin ^a   Miloudi, Khalil ^b   Shao, Zhuo ^a   Daudelin, Jean Francois ^a   Boulet, Salix ^a   Oubaha, Malika ^b   Beaudoin, Felix ^a   Akla, Naoufal ^a   Henriques, Sullivan ^a   Menard, Catherine ^a   Stahl, Andreas ^c   Delisle, Jean Sébastien ^a   Rezende, Flavio A ^a   Labrecque, Nathalie ^a   Sapieha, Przemyslaw ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPILIN 1; SEMAPHORIN 3A; VASCULOTROPIN; SEMA3A PROTEIN, HUMAN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; EXPERIMENTAL RETINOPATHY; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; MACROPHAGE; MICROGLIA; MONONUCLEAR PHAGOCYTE; NONHUMAN; PATHOGENESIS; REAL TIME POLYMERASE CHAIN REACTION; RETINA NEOVASCULARIZATION; RETINA NEUROEPITHELIAL LAYER; VITRECTOMY; VITREOUS BIOPSY; VITREOUS BODY; ADULT; AGED; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; CHOROID; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM; MIDDLE AGED; PHYSIOLOGY; TISSUE CULTURE TECHNIQUE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CHEMOTAXIS; CHOROID; DIABETIC RETINOPATHY; HUMANS; IMMUNITY, INNATE; MICE, INBRED C57BL; MIDDLE AGED; MONONUCLEAR PHAGOCYTE SYSTEM; MYELOID CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROIMMUNOMODULATION; NEUROPILIN-1; SEMAPHORIN-3A; TISSUE CULTURE TECHNIQUES;

EID: 84908632065     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI76492     Document Type: Article

References (58)

1. Lampron A, Elali A, Rivest S. Innate immunity in the CNS: redefining the relationship between the CNS and Its environment. Neuron. 2013;78(2):214-232.
2. Ousman SS, Kubes P. Immune surveillance in the central nervous system. Nat Neurosci. 2012;15(8):1096-1101.
3. Adamis AP, Berman AJ. Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol. 2008;30(2):65-84.
4. Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366(13):1227-1239.
5. Joussen AM, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004;18(12):1450-1452.
6. Ambati J, Fowler BJ. Mechanisms of age-related macular degeneration. Neuron. 2012;75(1):26-39.
7. Sennlaub F, et al. CCR2(+) monocytes infiltrate atrophic lesions in age-related macular disease and mediate photoreceptor degeneration in experimental subretinal inflammation in Cx3cr1 deficient mice. EMBO Mol Med. 2013;5(11):1775-1793.
8. Combadiere C, et al. CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest. 2007;117(10):2920-2928.
9. Dammann O. Inflammation and retinopathy of prematurity. Acta Paediatr. 2010;99(7):975-977.
10. Tremblay S, et al. Systemic inflammation perturbs developmental retinal angiogenesis and neuroretinal function. Invest Ophthalmol Vis Sci. 2013;54(13):8125-8139.
11. Hartnett ME, Penn JS. Mechanisms and management of retinopathy of prematurity. N Engl J Med. 2012;367(26):2515-2526.
12. Kempen JH, et al. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122(4):552-563.
13. Sapieha P, et al. Proliferative retinopathies: Angiogenesis that blinds. Int J Biochem Cell Biol. 2010;42(1):5-12.
14. Robinson GS, et al. Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development. FASEB J. 2001;15(7):1215-1217.
15. Saint-Geniez M, et al. Endogenous VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors. PLoS One. 2008;3(11):e3554.
16. Hellström A, Smith LE, Dammann O. Retinopathy of prematurity. Lancet. 2013;382(9902):1445-1457.
17. Sapieha P. Eyeing central neurons in vascular growth and reparative angiogenesis. Blood. 2012;120(11):2182-2194.
18. Kern TS, Barber AJ. Retinal ganglion cells in diabetes. J Physiol. 2008;586(pt 18):4401-4408.
19. Binet F, et al. Neuronal ER stress impedes myeloid- cell-induced vascular regeneration through IRE1α degradation of netrin-1. Cell Metab. 2013;17(3):353-371.
20. Cerani A, et al. Neuron-derived semaphorin 3A is an early inducer of vascular permeability in diabetic retinopathy via neuropilin-1. Cell Metab. 2013;18(4):505-518.
21. Joyal JS, et al. Ischemic neurons prevent vascular regeneration of neural tissue by secreting semaphorin 3A. Blood. 2011;117(22):6024-6035.
22. Checchin D, Sennlaub F, Levavasseur E, Leduc M, Chemtob S. Potential role of microglia in retinal blood vessel formation. Invest Ophthalmol Vis Sci. 2006;47(8):3595-3602.
23. Connor KM, et al. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med. 2007;13(7):868-873.
24. Sapieha P, et al. 5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of ω-3 polyunsaturated fatty acids. Sci Transl Med. 2011;3(69):69ra12.
25. Stahl A, et al. Short communication: PPAR gamma mediates a direct antiangiogenic effect of omega 3-PUFAs in proliferative retinopathy. Circ Res. 2010;107(4):495-500.
26. Smith LE, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994;35(1):101-111.
27. Lee P, Goishi K, Davidson AJ, Mannix R, Zon L, Klagsbrun M. Neuropilin-1 is required for vascular development and is a mediator of VEGFdependent angiogenesis in zebrafish. Proc Natl Acad Sci USA. 2002;99(16):10470-10475.
28. Gluzman-Poltorak Z, Cohen T, Shibuya M, Neufeld G. Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes. J Biol Chem. 2001;276(22):18688-18694.
29. Mamluk R, Gechtman Z, Kutcher ME, Gasiunas N, Gallagher J, Klagsbrun M. Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain. J Biol Chem. 2002;277(27):24818-24825.
30. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 1998;92(6):735-745.
31. Fantin A, et al. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood. 2010;116(5):829-840.
32. Carrer A, et al. Neuropilin-1 identifies a subset of bone marrow Gr1- monocytes that can induce tumor vessel normalization and inhibit tumor growth. Cancer Res. 2012;72(24):6371-6381.
33. Casazza A, et al. Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity. Cancer Cell. 2013;24(6):695-709.
34. Ritter MR, Banin E, Moreno SK, Aguilar E, Dorrell MI, Friedlander M. Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy. J Clin Invest. 2006;116(12):3266-3276.
35. Stahl A, et al. Postnatal weight gain modifies severity and functional outcome of oxygen-induced proliferative retinopathy. Am J Pathol. 2010;177(6):2715-2723.
36. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 1999;8(4):265-277.
37. Mattapallil MJ, et al. The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes. Invest Ophthalmol Vis Sci. 2012;53(6):2921-2927.
38. Klebanov O, Nitzan A, Raz D, Barzilai A, Solomon AS. Upregulation of Semaphorin 3A and the associated biochemical and cellular events in a rat model of retinal detachment. Graefes Arch Clin Exp Ophthalmol. 2009;247(1):73-86.
39. Koppel AM, Raper JA. Collapsin-1 covalently dimerizes, and dimerization is necessary for collapsing activity. J Biol Chem. 1998; 273(25):15708-15713.
40. Kubota Y, et al. M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis. J Exp Med. 2009;206(5):1089-1102.
41. Okuno Y, Nakamura-Ishizu A, Kishi K, Suda T, Kubota Y. Bone marrow-derived cells serve as proangiogenic macrophages but not endothelial cells in wound healing. Blood. 2011;117(19):5264-5272.
42. Neufeld G, Kessler O. The semaphorins: versatile regulators of tumour progression and tumour angiogenesis. Nat Rev Cancer. 2008;8(8):632-645.
43. Worthylake RA, Burridge K. RhoA and ROCK promote migration by limiting membrane protrusions. J Biol Chem. 2003;278(15):13578-13584.
44. Dammann O, et al. Immaturity, perinatal inflammation, and retinopathy of prematurity: A multi-hit hypothesis. Early Hum Dev. 2009;85(5):325-329.
45. Kastelan S, Tomic M, Gverovic Antunica A, Salopek Rabatic J, Ljubic S. Inflammation and pharmacological treatment in diabetic retinopathy. Mediators Inflamm. 2013;2013:213130.
46. Silva PS, Cavallerano JD, Sun JK, Aiello LM, Aiello LP. Effect of systemic medications on onset and progression of diabetic retinopathy. Nat Rev Endocrinol. 2010;6(9):494-508.
47. Miao HQ, Soker S, Feiner L, Alonso JL, Raper JA, Klagsbrun M. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J Cell Biol. 1999;146(1):233-242.
48. Klagsbrun M, Eichmann A. A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis. Cytokine Growth Factor Rev. 2005;16(4):535-548.
49. Guttmann-Raviv N, Shraga-Heled N, Varshavsky A, Guimaraes-Sternberg C, Kessler O, Neufeld G. Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis. J Biol Chem. 2007;282(36):26294-26305.
50. Neufeld G, Sabag AD, Rabinovicz N, Kessler O. Semaphorins in angiogenesis and tumor progression. Cold Spring Harb Perspect Med. 2012;2(1):a006718.
51. Bussolino F, Valdembri D, Caccavari F, Serini G. Semaphoring vascular morphogenesis. Endothelium. 2006;13(2):81-91.
52. Yancopoulos GD. Clinical application of therapies targeting VEGF. Cell. 2010;143(1):13-16.
53. Miloudi K, Dejda A, Binet F, Lapalme E, Cerani A, Sapieha P. Assessment of vascular regeneration in the CNS using the mouse retina. J Vis Exp. 2014;(88):e51351.
54. Sapieha P, et al. Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life. J Clin Invest. 2010;120(9):3022-3032.
55. Stahl A, et al. The mouse retina as an angiogenesis model. Invest Ophthalmol Vis Sci. 2010;51(6):2813-2826.
56. Stahl A, et al. Computer-aided quantification of retinal neovascularization. Angiogenesis. 2009;12(3):297-301.
57. Shao Z, et al. Choroid sprouting assay: An ex vivo model of microvascular angiogenesis. PLoS One. 2013;8(7):e69552.
58. van Rooijen N, van Kesteren-Hendrikx E. "In vivo" depletion of macrophages by liposome-mediated "suicide". Methods Enzymol. 2003;373:3-16.